DE3863963D1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number: DE3863963D1
Authority: DE; Germany
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1987-05-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE8888304007T

Other languages

English (en)

Inventor

Kevin Edward Pearmain

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Smith Kline and French Laboratories Ltd

GlaxoSmithKline LLC

Original Assignee

Smith Kline and French Laboratories Ltd

GlaxoSmithKline LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-08

Filing date

1988-05-04

Publication date

1991-09-05

1987-05-08 Priority claimed from GB878710966A external-priority patent/GB8710966D0/en

1987-05-08 Priority claimed from GB878710965A external-priority patent/GB8710965D0/en

1988-05-04 Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd

1991-09-05 Application granted granted Critical

1991-09-05 Publication of DE3863963D1 publication Critical patent/DE3863963D1/de

2008-05-05 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DE8888304007T 1987-05-08 1988-05-04 Pharmazeutische zusammensetzungen. Expired - Lifetime DE3863963D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB878710966A GB8710966D0 (en)	1987-05-08	1987-05-08	Pharmaceutical compositions
GB878710965A GB8710965D0 (en)	1987-05-08	1987-05-08	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
DE3863963D1 true DE3863963D1 (de)	1991-09-05

Family

ID=26292225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8888304007T Expired - Lifetime DE3863963D1 (de)	1987-05-08	1988-05-04	Pharmazeutische zusammensetzungen.

Country Status (12)

Country	Link
US (1)	US5188839A (de)
EP (1)	EP0290229B1 (de)
JP (1)	JP2721219B2 (de)
KR (1)	KR960011236B1 (de)
AU (1)	AU602582B2 (de)
DE (1)	DE3863963D1 (de)
ES (1)	ES2040339T3 (de)
GB (1)	GB2204489B (de)
GR (1)	GR3002410T3 (de)
IE (1)	IE61692B1 (de)
PT (1)	PT87423B (de)
WO (1)	WO1988008703A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5286489A (en) *	1985-08-26	1994-02-15	The Procter & Gamble Company	Taste masking compositions
GB8710965D0 (en) *	1987-05-08	1987-06-10	Smith Kline French Lab	Pharmaceutical compositions
DE3809764A1 (de) *	1988-03-23	1989-10-05	Knoll Ag	Mischung aus alginaten und polyacrylaten und deren verwendung
US5230901A (en) *	1988-03-23	1993-07-27	Knoll Ag	Sustained release tablet of a mixture of alginates and polyacrylates
ATE82680T1 (de) *	1988-05-04	1992-12-15	Smith Kline French Lab	Kautablette.
US5219563A (en) *	1988-05-11	1993-06-15	Glaxo Group Limited	Drug adsorbates
GB2222772B (en) *	1988-09-20	1992-05-13	Glaxo Group Ltd	Pharmaceutical compositions
ZA919510B (en) *	1990-12-05	1992-10-28	Smithkline Beecham Corp	Pharmaceutical compositions
US5380535A (en) *	1991-05-28	1995-01-10	Geyer; Robert P.	Chewable drug-delivery compositions and methods for preparing the same
US5320848A (en) *	1991-05-28	1994-06-14	Affinity Biotech, Inc.	Chewable drug-delivery composition
EG20380A (en) *	1991-10-16	1999-02-28	Richardson Vicks Inc	Enhanced skin penetration system for improved topical delivery of drugs
GB9127150D0 (en) *	1991-12-20	1992-02-19	Smithkline Beecham Plc	Novel treatment
US5294433A (en) *	1992-04-15	1994-03-15	The Procter & Gamble Company	Use of H-2 antagonists for treatment of gingivitis
US5578316A (en) *	1992-06-04	1996-11-26	Smithkline Beecham Corporation	Palatable pharmaceutical compositions
GB9224855D0 (en) *	1992-11-27	1993-01-13	Smithkline Beecham Plc	Pharmaceutical compositions
CA2110313C (en) *	1992-12-01	2004-10-26	Edward John Roche	Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5622980A (en) *	1993-08-17	1997-04-22	Applied Analytical Industries, Inc.	Oral compositions of H2-antagonists
US6818229B1 (en)	1993-09-20	2004-11-16	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en)	1993-09-20	2000-06-27	Bova; David J.	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) *	1993-09-20	2006-11-23	Eugenio Cefali	Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en)	1993-09-20	2004-06-08	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en)	1993-09-20	2004-01-13	Kos Pharmaceuticals, Inc.	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en)	1993-09-20	2000-10-10	Bova; David J.	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
SE9600071D0 (sv) †	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
BR9709452B1 (pt) *	1996-05-13	2008-11-18		sistema de liberaÇço bucal na forma de uma pastilha degastÁvel.
US20010014340A1 (en) *	1996-06-14	2001-08-16	Motohiro Ohta	Intrabuccally rapidly disintegrating tablet
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5989588A (en) *	1996-10-04	1999-11-23	Merck & Co., Inc.	Methods and compositions for preventing and treating heartburn
ES2274550T3 (es) *	1996-10-04	2007-05-16	MERCK & CO., INC.	Procedimientos y composiciones para prevenir y tratar ardor de estomago.
FR2766089B1 (fr) †	1997-07-21	2000-06-02	Prographarm Lab	Comprime multiparticulaire perfectionne a delitement rapide
IN186245B (de)	1997-09-19	2001-07-14	Ranbaxy Lab Ltd
CA2349575A1 (en)	1998-11-17	2000-05-25	Nitromed, Inc.	Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
FR2794979B1 (fr) *	1999-06-21	2001-07-27	Patrick Veret	Une nouvelle formulation de comprime composee de lactose, sorbitol, stearate de magnesium
PT1276470E (pt)	2000-04-20	2007-08-13	Novartis Ag	Composição de revestimento para dissimular o sabor
US6551617B1 (en)	2000-04-20	2003-04-22	Bristol-Myers Squibb Company	Taste masking coating composition
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
AU2003209673B2 (en) *	2002-03-08	2007-10-18	M/S. Ind-Swift Limited	Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
US8367111B2 (en)	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
ITMI20041255A1 (it) *	2004-06-22	2004-09-22	Univ Degli Studi Milano	Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US20060127479A1 (en) *	2004-10-08	2006-06-15	Natrajan Kumaraperumal	Solvent free taste masked pharmaceutical compositions
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
NZ589750A (en)	2004-10-21	2012-07-27	Aptalis Pharmatech Inc	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
WO2007090113A2 (en)	2006-02-01	2007-08-09	Weg Stuart L	Use of antifungal compositions to treat upper gastrointestinal conditions
CA2782285A1 (en)	2009-12-02	2011-06-09	Luigi Mapelli	Fexofenadine microcapsules and compositions containing them

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5840529B2 (ja) *	1975-09-29	1983-09-06	明治製菓株式会社	ケイコウヨウセイザイノセイホウ
JPS5513239A (en) *	1978-07-14	1980-01-30	Fujisawa Pharmaceut Co Ltd	Fine particulate drug composition
JPS5567375A (en) *	1978-11-17	1980-05-21	Harunobu Miura	Automatic washer
JPS56164122A (en) *	1980-05-21	1981-12-17	Fujimoto Seiyaku Kk	Drug composition comprising cimetidine as main agent
JPS58201725A (ja) *	1982-05-19	1983-11-24	Eisai Co Ltd	褐変化防止組成物
EP0205336B1 (de) *	1985-06-11	1991-09-11	Teijin Limited	Oral-Arzneizubereitung mit Retardwirkung
FR2593065B1 (fr) *	1986-01-22	1988-09-09	Smith Kline French Lab	Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
US4800087A (en) *	1986-11-24	1989-01-24	Mehta Atul M	Taste-masked pharmaceutical compositions
JPS63188621A (ja) *	1987-01-30	1988-08-04	Taisho Pharmaceut Co Ltd	矯味経口製剤
GB8710965D0 (en) *	1987-05-08	1987-06-10	Smith Kline French Lab	Pharmaceutical compositions

1987
- 1987-05-04 KR KR1019890700007A patent/KR960011236B1/ko not_active IP Right Cessation
1988
- 1988-05-04 JP JP63503930A patent/JP2721219B2/ja not_active Expired - Lifetime
- 1988-05-04 EP EP88304007A patent/EP0290229B1/de not_active Expired - Lifetime
- 1988-05-04 ES ES198888304007T patent/ES2040339T3/es not_active Expired - Lifetime
- 1988-05-04 DE DE8888304007T patent/DE3863963D1/de not_active Expired - Lifetime
- 1988-05-04 GB GB8810477A patent/GB2204489B/en not_active Revoked
- 1988-05-04 US US07/295,190 patent/US5188839A/en not_active Expired - Lifetime
- 1988-05-04 WO PCT/GB1988/000349 patent/WO1988008703A1/en unknown
- 1988-05-04 AU AU17140/88A patent/AU602582B2/en not_active Expired
- 1988-05-05 PT PT87423A patent/PT87423B/pt not_active IP Right Cessation
- 1988-05-06 IE IE136888A patent/IE61692B1/en not_active IP Right Cessation
1991
- 1991-08-01 GR GR91401072T patent/GR3002410T3/el unknown

Also Published As

Publication number	Publication date
PT87423A (pt)	1989-05-31
IE881368L (en)	1988-11-08
AU1714088A (en)	1988-12-06
JP2721219B2 (ja)	1998-03-04
EP0290229B1 (de)	1991-07-31
ES2040339T3 (es)	1993-10-16
GB8810477D0 (en)	1988-06-08
EP0290229A1 (de)	1988-11-09
GB2204489B (en)	1990-11-14
KR890701101A (ko)	1989-12-19
KR960011236B1 (ko)	1996-08-21
US5188839A (en)	1993-02-23
PT87423B (pt)	1992-09-30
GR3002410T3 (en)	1992-12-30
AU602582B2 (en)	1990-10-18
IE61692B1 (en)	1994-11-16
JPH01503385A (ja)	1989-11-16
WO1988008703A1 (en)	1988-11-17
GB2204489A (en)	1988-11-16

Legal Events

Date	Code	Title	Description
1992-08-27	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE3863963D1 (de)	1991-09-05	Pharmazeutische zusammensetzungen.
DE3868986D1 (de)	1992-04-16	Pharmazeutische zusammensetzungen.
DE68901417D1 (de)	1992-06-11	Pharmazeutische zusammensetzung.
DE122004000023I2 (de)	2009-05-07	Pharmazeutische Zusammensetzung
DE68911473T2 (de)	1994-05-05	Arzneimittelformulierungen.
FI901102A0 (fi)	1990-03-05	Farmaceutiska kompositioner.
FI922364A0 (fi)	1992-05-22	Farmaceutiska kompositioner.
DE3586545D1 (de)	1992-09-24	Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE3486255T2 (de)	1994-03-24	Pharmazeutische Zusammensetzungen.
DE3483133D1 (de)	1990-10-11	Pharmazeutische zusammensetzungen.
DE69006094D1 (de)	1994-03-03	Pharmazeutische Zusammensetzungen.
DE69115263D1 (de)	1996-01-18	Pharmazeutische zusammensetzungen.
DE3484098D1 (de)	1991-03-14	Pharmazeutische zusammensetzungen.
IT8820386A0 (it)	1988-04-29	Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A (fi)	1990-02-19	Farmaceutiska kompositioner.
DE3682083D1 (de)	1991-11-28	Pharmazeutische zusammensetzungen.
FI872733A0 (fi)	1987-06-18	Farmaceutiska kompositioner.
FI872313A (fi)	1987-11-28	Farmaceutiska kompositioner.
FI883673A (fi)	1989-02-07	Farmaceutiska kompositioner.
DE3674040D1 (de)	1990-10-18	Pharmazeutische zusammensetzungen.
DE3866789D1 (de)	1992-01-23	Pharmazeutische zusammensetzungen.
DE3483900D1 (de)	1991-02-14	Pharmazeutische zusammensetzungen.
DE68907609T2 (de)	1994-03-10	Arzneimittelzusammensetzung.
ATE78161T1 (de)	1992-08-15	4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE3768109D1 (de)	1991-04-04	Pharmazeutische zusammensetzungen.